via @NYTimes: The F.D.A. has now begun what is known as a “for cause” inspection of the plant. Such inquiries are typically prompted by specific complaints. https://t.co/JolMsj0Sjl
A top government manufacturing expert warned in June about "the need for extensive training of personnel, and strengthening of the quality function" at the Emergent plant. https://t.co/kBi6lLltH3
Tossed batches, mold, virus cells suffocated with the wrong gas. A record of lapses at Emergent’s Baltimore plant led up to major loss of J&J doses. With @ChrisDHamby and @SherylNYThttps://t.co/YTulyqxyJD
Decisions about what to do with extra orders must be made within weeks, or the uncertainty could slow production lines. With @noahweilandhttps://t.co/Vy5PR44RlA
Federal officials confirm, again, what @SharonLNYT and @noahweiland reported weeks ago: Johnson & Johnson is still significantly behind on production targets https://t.co/GDQz3T1G8F
"100 percent effective against death and hospitalizations?That's all I need to know," said Dr. Danny Avula, Virginia's vaccine coordinator. With @noahweilandhttps://t.co/xapWp7eF9s
The avalanche of legislation also raises fundamental questions about the ability of a minority of voters to exert majority control in American politics, writes @miwinehttps://t.co/LXDAes93K0